Delivery Order SPE2DB20D3304-SPE2DB25FW6C7

Award Date 4/9/25
Potential Completion Date 4/10/25
Potential Value $4.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568520442 - Progesterone 200 mg Capsule 30s, a pharmaceutical product, with a ceiling value of $14,022.32. The contract is a Delivery Order, with a Firm Fixed Price pricing type. The ultimate completion date is June 12, 2025. This award is not designated as a set-aside contract....
This federal contract award, valued at $18,557.07, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567752016 - Progesterone 200 mg Capsule 100s. This appears to be a Firm Fixed Price Delivery Order contract with an ultimate completion date of April 1, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,611,389 units of 200 mg progesterone capsules in 100-count bottles, with a ceiling value of $6,899.45. The contract has an ultimate completion date of March 19, 2025 and was awarded on March 18, 2025. It is a firm fixed-price delivery order contract with no set-aside designation,...
This federal contract award, valued at $22,962.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567908583 - Progesterone 200 mg Capsule 100s, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 15, 2025. The contract is not set aside for any specific business category. Amerisourcebergen...
This federal contract award, identified as SPE2DB25D3504|SPE2DB25FVUHD, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,377.50 firm fixed-price delivery order is for the supply of 4567944647 - Progesterone 100 mg Capsule 100s. The contract has an ultimate completion date of April 17, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $4,844.16, is for the delivery of Progesterone 200 mg capsules. It is a firm fixed-price delivery order contract with an ultimate completion date of April 10, 2025. The contract is not designated with a set-aside, indicating open competition. AmerisourceBergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Progesterone 200 mg capsules, a pharmaceutical product, with a ceiling value of $12,455.23. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is May 1, 2025. The contract is not set aside and is open to competition....
This federal contract award, with ID SPE2DB24D1021|SPE2DB25FEVZH, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $7,534.29 firm fixed-price delivery order is for the supply of 4,567,941,121 units of the 200 mg progesterone capsule product. The contract has an ultimate completion date of April 17, 2025 and is not set aside. Amerisourcebergen Drug Corp is the prime contractor, and this award is associated with the...
This federal contract award, with ID SPE2DB20D2104|SPE2DB25FMKFT, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567459910 - Progesterone 200 mg Capsule 100s, with a firm fixed price of $9,144.58 and a completion date of March 5, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,050.38 firm fixed-price delivery order is for the supply of 4567199427 - Progesterone 100 mg Capsule 30s. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
  • SPE2DB20D3304
    Indefinite Delivery Contract
  • SPE2DB20D3304-SPE2DB25FW6C7
    Delivery Order

This federal contract award, with ID SPE2DB20D3304|SPE2DB25FW6C7, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567861501 - Progesterone 100 mg Capsule 100s, a pharmaceutical product, with a ceiling value of $4,062.16. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is April 10, 2025. This award is not associated with any set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 7/9/25, 10:08 AM